drugset / Trial / NCT03728478

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS

NCT03728478

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to compare the effectiveness of a conventional therapeutic regimen, based on treatment escalation (step-up strategy) and driven by the treat-to-target approach, with that of an early aggressive intervention based on the initial start of a combination of conventional and biological DMARDs (step-down strategy).

Timeline

Start
2019-05-29
Primary completion
2025-02-28
Completion
2025-02-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 0.8 mg/kg Subcutaneous
Subject Methotrexate Small molecule 15 mg/m2 Subcutaneous
Subject Methylprednisolone Other / unclassified Other
Subject Triamcinolone Hexacetonide Other / unclassified Other